Sierra Summit Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.82M Buy
21,917
+354
+2% +$41.4K 0.31% 52
2026
Q1
$2.59M Buy
21,563
+1,443
+7% +$167K 0.38% 49
2025
Q4
$2.12M Buy
20,120
+417
+2% +$39.1K 0.32% 52
2025
Q3
$1.65M Buy
19,703
+820
+4% +$67.5K 0.25% 61
2025
Q2
$1.49M Buy
18,883
+8,213
+77% +$653K 0.27% 60
2025
Q1
$958K Buy
10,670
+1,499
+16% +$140K 0.21% 74
2024
Q4
$912K Buy
9,171
+2,231
+32% +$230K 0.18% 71
2024
Q3
$788K Sell
6,940
-30
-0.4% -$3.56K 0.18% 77
2024
Q2
$863K Buy
6,970
+877
+14% +$113K 0.21% 58
2024
Q1
$804K Buy
6,093
+349
+6% +$43K 0.22% 55
2023
Q4
$626K Buy
+5,744
New +$596K 0.18% 73

Other funds holding MRK

Sierra Summit Advisors's MRK Position: Q2 2026 in Review

Sierra Summit Advisors increased its Merck (MRK) stake by 1.6% in Q2 2026, buying an estimated $41.4K and bringing the position to 21,917 shares worth $2.82M. The position accounts for 0.31% of the portfolio, ranked #52.

Sierra Summit Advisors first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sierra Summit Advisors held 21,917 shares of Merck worth $2.82M as of Q2 2026.
  • Sierra Summit Advisors bought 354 Merck shares in Q2 2026, an estimated $41.4K.
  • Merck made up 0.31% of Sierra Summit Advisors's portfolio in Q2 2026, its #52 holding.
  • Sierra Summit Advisors first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sierra Summit Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.